Please login to the form below
off-label information
This page shows the latest off-label information news and features for those working in and with pharma, biotech and healthcare.
Celebrating excellence
The Lilly Medical Cascade, which is currently being rolled-out throughout the industry, across brands and around the world, can be used for both on- and off-label information. ... The PMEA judges said: “This was a real first - a verified product
Latest news
-
Blue Latitude's industry-first praised at PMEA
The Lilly Medical Cascade, which is currently being rolled-out throughout the industry, across brands and around the world, can be used for both on- and off-label information. ... The PMEA judges said: “This was a real first - a verified product
-
Pharma lobbying in the US
That we need to distinguish between 'active' off-label promotion and unsolicited off-label requests from clinicians because somewhere and somehow the information that helps advance treatment needs to be shared. ... It has become a conversation about how
-
FDA releases draft social media guidance
no other control or influence on that site, then the firm is not responsible for information on a third-party site. • ... It will then add to a growing body of digital guidance from the FDA that so far covers off-label information on social media and a
-
US think tank suggests ‘social guiding principles’ for pharma
The regulator held a two-day public hearing on pharma's use of social media and the internet in November 2009 but, apart from some direction on how to treat ... label information requests, has yet to publish guidance on the area.
-
FDA boosts its social media use with the launch of a new blog
Through FDA Voice the regulator aims to provide “information from behind the scenes here at FDA”, as FDA Commissioner Margaret Hamburg put in an introductory post. ... But the Agency's recommendations were limited to how pharma companies respond to
More from news
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
How to build an online medical information service that resonates with your customers
For example, in many European countries, healthcare professionals need to verify their professions before accessing on-label and off-label information.This not only has legal implications but also impacts the ... Search engine optimisation (SEO) can help
-
Medical Information Letters in the 21st Century: An Innovative Approach to Unsolicited Questions
. Medical Information Letters in the 21st Century: An Innovative Approach to Unsolicited Questions.
-
Blue Latitude Health wins PMEA 2015 Innovation award
Lilly Medical Cascade is a ground breaking new way for HCPs to quickly, easily and securely access medical product information – both on and off label. ... For more information about Blue Latitude Health, contact Sophie Berger, Marketing Manager, at:
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
